Possible Efficacy of Lilly's Necitumumab (IMC-11F8) In Lung Cancer Subset Forbes, 14 Aug 2013 Eli Lilly announced yesterday their very preliminary and non-quantitative conclusions on the SQUIRE study, a 1093-patient Phase…